Nature Communications (Oct 2022)
SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
- Adam Abdullahi,
- David Oladele,
- Michael Owusu,
- Steven A. Kemp,
- James Ayorinde,
- Abideen Salako,
- Douglas Fink,
- Fehintola Ige,
- Isabella A. T. M. Ferreira,
- Bo Meng,
- Augustina Angelina Sylverken,
- Chika Onwuamah,
- Kwame Ofori Boadu,
- Kazeem Osuolale,
- James Opoku Frimpong,
- Rufai Abubakar,
- Azuka Okuruawe,
- Haruna Wisso Abdullahi,
- Gideon Liboro,
- Lawrence Duah Agyemang,
- Nana Kwame Ayisi-Boateng,
- Oluwatosin Odubela,
- Gregory Ohihoin,
- Oliver Ezechi,
- Japhet Senyo Kamasah,
- Emmanuel Ameyaw,
- Joshua Arthur,
- Derrick Boakye Kyei,
- Dorcas Ohui Owusu,
- Olagoke Usman,
- Sunday Mogaji,
- Adedamola Dada,
- George Agyei,
- Soraya Ebrahimi,
- Lourdes Ceron Gutierrez,
- Sani H. Aliyu,
- Rainer Doffinger,
- Rosemary Audu,
- Richard Adegbola,
- Petra Mlcochova,
- Richard Odame Phillips,
- Babatunde Lawal Solako,
- Ravindra K. Gupta
Affiliations
- Adam Abdullahi
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- David Oladele
- Nigeria Institute of Medical Research (NIMR)
- Michael Owusu
- Kwame Nkrumah University of Science and Technology
- Steven A. Kemp
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- James Ayorinde
- Nigeria Institute of Medical Research (NIMR)
- Abideen Salako
- Nigeria Institute of Medical Research (NIMR)
- Douglas Fink
- Faculty of Infection and Tropical Diseases, London School of Hygiene and Tropical Medicine
- Fehintola Ige
- Nigeria Institute of Medical Research (NIMR)
- Isabella A. T. M. Ferreira
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- Bo Meng
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- Augustina Angelina Sylverken
- Kwame Nkrumah University of Science and Technology
- Chika Onwuamah
- Nigeria Institute of Medical Research (NIMR)
- Kwame Ofori Boadu
- Kumasi South Hospital
- Kazeem Osuolale
- Nigeria Institute of Medical Research (NIMR)
- James Opoku Frimpong
- Kwame Nkrumah University of Science and Technology
- Rufai Abubakar
- Nigeria Institute of Medical Research (NIMR)
- Azuka Okuruawe
- Nigeria Institute of Medical Research (NIMR)
- Haruna Wisso Abdullahi
- Institute of Human Virology
- Gideon Liboro
- Nigeria Institute of Medical Research (NIMR)
- Lawrence Duah Agyemang
- Komfo Anokye Teaching Hospital
- Nana Kwame Ayisi-Boateng
- Kwame Nkrumah University of Science and Technology
- Oluwatosin Odubela
- Nigeria Institute of Medical Research (NIMR)
- Gregory Ohihoin
- Nigeria Institute of Medical Research (NIMR)
- Oliver Ezechi
- Nigeria Institute of Medical Research (NIMR)
- Japhet Senyo Kamasah
- Kwame Nkrumah University of Science and Technology
- Emmanuel Ameyaw
- Kwame Nkrumah University of Science and Technology
- Joshua Arthur
- Komfo Anokye Teaching Hospital
- Derrick Boakye Kyei
- Kumasi Centre for Collaborative Research in Tropical Medicine
- Dorcas Ohui Owusu
- Kwame Nkrumah University of Science and Technology
- Olagoke Usman
- Federal Medical Centre
- Sunday Mogaji
- Federal Medical Centre
- Adedamola Dada
- Federal Medical Centre
- George Agyei
- Kwadaso Seventh Day Adventist Hospital
- Soraya Ebrahimi
- Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust
- Lourdes Ceron Gutierrez
- Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust
- Sani H. Aliyu
- Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust
- Rainer Doffinger
- Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust
- Rosemary Audu
- Nigeria Institute of Medical Research (NIMR)
- Richard Adegbola
- Nigeria Institute of Medical Research (NIMR)
- Petra Mlcochova
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- Richard Odame Phillips
- Kwame Nkrumah University of Science and Technology
- Babatunde Lawal Solako
- Nigeria Institute of Medical Research (NIMR)
- Ravindra K. Gupta
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)
- DOI
- https://doi.org/10.1038/s41467-022-33792-x
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 11
Abstract
Data on immune response to the SARS-COV-2 AZD1222 vaccine are limited in African populations. Here, the authors show immunogenicity of the AZD1222 vaccine in two independent cohorts from West Africa, including seroprevalence levels prior to vaccine rollout in January 2021.
